Insider: Bender Jeremy CHIEF EXECUTIVE OFFICER - Day One Biopharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 161,365 | 0 | 161,365 |
| Value | $1,091,811.73 | $0.00 | $1,091,811.73 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/18/2025 | DDS | 16,058 | Direct | COM | $6.77 | $108,666.09 | 161,365 |
| 05/16/2025 | DDS | 13,964 | Direct | COM | $6.26 | $87,385.32 | 145,737 |
| 02/18/2025 | DDS | 12,048 | Direct | COM | $11.96 | $144,130.22 | 128,015 |
| 11/18/2024 | DDS | 10,554 | Direct | COM | $13.21 | $139,420.45 | 108,377 |
| 08/16/2024 | DDS | 10,681 | Direct | COM | $14.00 | $149,524.39 | 98,932 |
| 05/16/2024 | DDS | 7,873 | Direct | COM | $16.08 | $126,587.61 | 654,728 |
| 05/03/2024 | DDS | 9,154 | Direct | COM | $17.85 | $163,417.21 | 642,602 |
| 05/02/2024 | DDS | 6 | Direct | COM | $17.94 | $107.63 | 651,756 |
| 05/01/2024 | DDS | 70,051 | Direct | COM | $17.88 | $1,252,182.64 | 651,762 |
| 02/16/2024 | DDS | 7,615 | Direct | COM | $15.25 | $116,114.28 | 721,813 |
| 11/16/2023 | DDS | 3,107 | Direct | COM | $11.69 | $36,320.83 | 709,429 |
| 08/17/2023 | DDS | 2,996 | Direct | COM | $13.86 | $41,524.56 | 704,224 |
| 05/16/2023 | DDS | 3,104 | Direct | COM | $13.12 | $40,731.62 | 1,179,484 |
| 03/07/2023 | DDS | 12,500 | Direct | COM | $20.01 | $250,113.75 | 1,174,276 |
| 02/16/2023 | DDS | 3,022 | Direct | COM | $19.57 | $59,149.61 | 1,186,776 |
| 01/23/2023 | DDS | 12,500 | Direct | COM | $22.00 | $274,987.50 | 1,181,486 |
| 12/21/2022 | DDS | 12,500 | Direct | COM | $20.32 | $253,968.75 | 1,192,424 |
| 11/21/2022 | DDS | 12,100 | Direct | COM | $20.74 | $250,927.38 | 1,205,324 |
| 11/21/2022 | DDS | 400 | Direct | COM | $21.38 | $8,552.00 | 1,204,924 |
| 11/16/2022 | DDS | 1,513 | Direct | COM | $21.46 | $32,468.68 | 1,217,424 |
| 11/01/2022 | DDS | 12,500 | Direct | COM | $20.03 | $250,355.00 | 1,215,375 |
| 10/03/2022 | DDS | 12,500 | Direct | COM | $20.05 | $250,646.25 | 1,227,875 |
| 09/01/2022 | DDS | 1,859 | Direct | COM | $23.79 | $44,226.54 | 1,240,375 |
| 09/01/2022 | DDS | 10,641 | Direct | COM | $23.15 | $246,354.05 | 1,242,234 |
| 09/01/2022 | DDS | 10,641 | Direct | COM | $23.15 | $246,354.05 | 1,242,234 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research